Reporting earnings March 15th, we believe the technicals are inside information telling us AOB will beat earnings and raise guidance. Pennant formation resolving to the upside. MACD turning up, RSI 50 cross. Moving averages being taken down by the bulls, all point to good profits for longs.
This trades in the Drug/Bio sector, part of our bottoms up industry approved trading list.
No comments:
Post a Comment